section name header

Pronunciation ⬇

kee-toe-KOE-na-zole

Classifications ⬆ ⬇

Therapeutic Classification: antifungals (systemic)

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Spectrum:

Pharmacokinetics ⬆ ⬇

Absorption: Absorption from the GI tract is pH dependent; increasing pH decreases absorption.

Distribution: Widely distributed. CNS penetration is unpredictable and minimal. Crosses the placenta; enters breast milk.

Protein Binding: 99%.

Metabolism/Excretion: Partially metabolized by the liver. Excreted in feces via biliary excretion.

Half-life: 8 hr.

Time/Action Profile ⬆ ⬇

(blood levels)

ROUTEONSETPEAKDURATION
POrapid1–4 hr24 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CNS: dizziness , drowsiness.

EENT: photophobia.

CV: TORSADES DE POINTES , QT interval prolongation.

GI: HEPATOTOXICITY , nausea , vomiting , abdominal pain , constipation , diarrhea , flatulence.

GU: azoospermia , ↓ male libido , menstrual irregularities , oligospermia.

Derm: rash , urticaria.

Endo: adrenal insufficiency , gynecomastia.

Misc: ANAPHYLAXIS.

Interactions ⬆ ⬇

Drug-Drug:

Route/Dosage ⬆ ⬇

see Calculator

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Nizoral

Pot. Nursing Diagnoses ⬆ ⬇

Code ⬆

NDC Code*